NHAS
TTPH

Novo Holdings A/S’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Novo Holdings A/S’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,571
Closed -$8.48M – 20
2015
Q1 		$8.48M Sell
11,571
-62,179
-84% -$46.7M 0.72% 13
2014
Q4 		$58.6M Buy
73,750
+28,750
+64% +$15.5M 4.74% 8
2014
Q3 		$18M Hold
45,000
– – 1.75% 10
2014
Q2 		$12.1M Hold
45,000
– – 1.2% 9
2014
Q1 		$9.8M Sell
45,000
-15,000
-25% -$4.18M 1.21% 7
2013
Q4 		$16.2M Buy
+60,000
New +$14.3M 2.38% 5

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Novo Holdings A/S's TTPH Position: Q2 2015 in Review

Novo Holdings A/S sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2015, closing a stake of 11,571 shares — an estimated $8.48M sold.

Novo Holdings A/S first reported a position in TTPH in Q4 2013 and held it in 6 quarters. The position peaked at $58.6M in Q4 2014. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

  • Novo Holdings A/S reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Novo Holdings A/S sold 11,571 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $8.48M.
  • Novo Holdings A/S first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 6 quarters.
  • Novo Holdings A/S's Tetraphase Pharmaceuticals, Inc. position peaked at $58.6M in Q4 2014.
  • 139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Novo Holdings A/S's 13F filing for Q2 2015, filed 14 Aug 2015.